156 related articles for article (PubMed ID: 33205203)
1. Concurrent Infection With Multiple Human Papillomavirus Types Among Unvaccinated and Vaccinated 17-Year-Old Norwegian Girls.
Laake I; Feiring B; Jonassen CM; Pettersson JHO; Frengen TG; Kirkeleite IØ; Trogstad L
J Infect Dis; 2022 Sep; 226(4):625-633. PubMed ID: 33205203
[TBL] [Abstract][Full Text] [Related]
2. Substantial Decline in Prevalence of Vaccine-Type and Nonvaccine-Type Human Papillomavirus (HPV) in Vaccinated and Unvaccinated Girls 5 Years After Implementing HPV Vaccine in Norway.
Feiring B; Laake I; Christiansen IK; Hansen M; Stålcrantz J; Ambur OH; Magnus P; Jonassen CM; Trogstad L
J Infect Dis; 2018 Nov; 218(12):1900-1910. PubMed ID: 30010913
[TBL] [Abstract][Full Text] [Related]
3. An observational study comparing HPV prevalence and type distribution between HPV-vaccinated and -unvaccinated girls after introduction of school-based HPV vaccination in Norway.
Enerly E; Flingtorp R; Christiansen IK; Campbell S; Hansen M; Myklebust TÅ; Weiderpass E; Nygård M
PLoS One; 2019; 14(10):e0223612. PubMed ID: 31600341
[TBL] [Abstract][Full Text] [Related]
4. Optimization of a protocol for the evaluation of antibody responses to human papillomavirus (HPV) vaccination in low-resource settings.
Donkoh ET; Dassah ET; Owusu-Dabo E
BMC Womens Health; 2022 Jun; 22(1):234. PubMed ID: 35710373
[TBL] [Abstract][Full Text] [Related]
5. Human Papillomavirus Antibody Levels Following Vaccination or Natural Infection Among Young Men Who Have Sex With Men.
Chow EPF; Fairley CK; Zou H; Wigan R; Garland SM; Cornall AM; Atchison S; Tabrizi SN; Chen MY
Clin Infect Dis; 2022 Aug; 75(2):323-329. PubMed ID: 34971362
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of genital HPV infections and HPV serology in adolescent girls, prior to vaccination.
Mollers M; Scherpenisse M; van der Klis FR; King AJ; van Rossum TG; van Logchem EM; Feltkamp MC; Meijer CJ; Snijders PJ; Boot HJ; de Melker HE
Cancer Epidemiol; 2012 Dec; 36(6):519-24. PubMed ID: 22906483
[TBL] [Abstract][Full Text] [Related]
7. A single dose of quadrivalent human papillomavirus (HPV) vaccine is immunogenic and reduces HPV detection rates in young women in Mongolia, six years after vaccination.
Batmunkh T; Dalmau MT; Munkhsaikhan ME; Khorolsuren T; Namjil N; Surenjav U; Toh ZQ; Licciardi PV; Russell FM; Garland SM; Mulholland K; von Mollendorf C
Vaccine; 2020 Jun; 38(27):4316-4324. PubMed ID: 32387009
[TBL] [Abstract][Full Text] [Related]
8. Partner-Level and Sexual Networking Factors Are Associated With Vaccine-Type and Nonvaccine-Type Human Papillomavirus Infection After Vaccine Introduction in Young Women.
Kahn J; Washington C; Ding L; Wyllie T; Rosen B; Gorbach P
Sex Transm Dis; 2022 Jun; 49(6):429-436. PubMed ID: 35093984
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus prevalence and risk factors among Australian women 9-12 years after vaccine program introduction.
Shilling H; Garland SM; Atchison S; Cornall AM; Brotherton JML; Bateson D; McNamee K; Kaldor JM; Hocking JS; Chen MY; Fairley CK; McNulty A; Bell C; Marshall L; Ooi C; Skinner SR; Murray G; Molano M; Tabrizi S; Machalek DA
Vaccine; 2021 Aug; 39(34):4856-4863. PubMed ID: 34281743
[TBL] [Abstract][Full Text] [Related]
10. Occurrence of human papillomavirus (HPV) type replacement by sexual risk-taking behaviour group: Post-hoc analysis of a community randomized clinical trial up to 9 years after vaccination (IV).
Gray P; Luostarinen T; Vänskä S; Eriksson T; Lagheden C; Man I; Palmroth J; Pimenoff VN; Söderlund-Strand A; Dillner J; Lehtinen M
Int J Cancer; 2019 Aug; 145(3):785-796. PubMed ID: 30719706
[TBL] [Abstract][Full Text] [Related]
11. Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study.
Tabrizi SN; Brotherton JM; Kaldor JM; Skinner SR; Liu B; Bateson D; McNamee K; Garefalakis M; Phillips S; Cummins E; Malloy M; Garland SM
Lancet Infect Dis; 2014 Oct; 14(10):958-66. PubMed ID: 25107680
[TBL] [Abstract][Full Text] [Related]
12. Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study.
Kavanagh K; Pollock KG; Cuschieri K; Palmer T; Cameron RL; Watt C; Bhatia R; Moore C; Cubie H; Cruickshank M; Robertson C
Lancet Infect Dis; 2017 Dec; 17(12):1293-1302. PubMed ID: 28965955
[TBL] [Abstract][Full Text] [Related]
13. Baseline prevalence and type distribution of Human papillomavirus in sexually active non-vaccinated adolescent girls from Argentina.
González JV; Deluca GD; Liotta DJ; Correa RM; Basiletti JA; Colucci MC; Katz N; Vizzotti C; Picconi MA; ;
Rev Argent Microbiol; 2021; 53(1):11-19. PubMed ID: 32788072
[TBL] [Abstract][Full Text] [Related]
14. Population Impact of Girls-Only Human Papillomavirus 16/18 Vaccination in The Netherlands: Cross-Protective and Second-Order Herd Effects.
Hoes J; Woestenberg PJ; Bogaards JA; King AJ; de Melker HE; Berkhof J; Hoebe CJPA; van der Sande MAB; van Benthem BHB;
Clin Infect Dis; 2021 Mar; 72(5):e103-e111. PubMed ID: 33249475
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of HPV type-replacement in unvaccinated and vaccinated adolescent females-Post-hoc analysis of a community-randomized clinical trial (II).
Gray P; Palmroth J; Luostarinen T; Apter D; Dubin G; Garnett G; Eriksson T; Natunen K; Merikukka M; Pimenoff V; Söderlund-Strand A; Vänskä S; Paavonen J; Pukkala E; Dillner J; Lehtinen M
Int J Cancer; 2018 Jun; 142(12):2491-2500. PubMed ID: 29377141
[TBL] [Abstract][Full Text] [Related]
16. HPV cervical infections and serological status in vaccinated and unvaccinated women.
Murall CL; Reyné B; Selinger C; Bernat C; Boué V; Grasset S; Groc S; Rahmoun M; Bender N; Bonneau M; Foulongne V; Graf C; Picot E; Picot MC; Tribout V; Waterboer T; Bravo IG; Reynes J; Segondy M; Boulle N; Alizon S
Vaccine; 2020 Dec; 38(51):8167-8174. PubMed ID: 33168348
[TBL] [Abstract][Full Text] [Related]
17. Pattern of multiple human papillomavirus infection and type competition: An analysis in healthy Chinese women aged 18-45 years.
Su Y; Zheng T; Bi Z; Jia X; Li Y; Kuang X; Yang Y; Chen Q; Lin H; Huang Y; Huang S; Qiao Y; Wu T; Zhang J; Xia N
Hum Vaccin Immunother; 2024 Dec; 20(1):2334474. PubMed ID: 38619081
[TBL] [Abstract][Full Text] [Related]
18. Vaccine Hesitancy Drives Low Human Papillomavirus Vaccination Coverage in Girls Attending Public Schools in South Africa.
Khosa LA; Meyer JC; Motshwane FMM; Dochez C; Burnett RJ
Front Public Health; 2022; 10():860809. PubMed ID: 35685759
[TBL] [Abstract][Full Text] [Related]
19. Monitoring vaccine and non-vaccine HPV type prevalence in the post-vaccination era in women living in the Basilicata region, Italy.
Carozzi F; Puliti D; Ocello C; Anastasio PS; Moliterni EA; Perinetti E; Serradell L; Burroni E; Confortini M; Mantellini P; Zappa M; Dominiak-Felden G
BMC Infect Dis; 2018 Jan; 18(1):38. PubMed ID: 29334901
[TBL] [Abstract][Full Text] [Related]
20. Incidence and Types of Human Papillomavirus Infections in Adolescent Girls and Young Women Immunized With the Human Papillomavirus Vaccine.
Schlecht NF; Diaz A; Nucci-Sack A; Shyhalla K; Shankar V; Guillot M; Hollman D; Strickler HD; Burk RD
JAMA Netw Open; 2021 Aug; 4(8):e2121893. PubMed ID: 34424304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]